Back
Novavax Vs. ResMed Industry Stock Comparison
Buy
66
NVAX
Novavax
Last Price:
13.09
Seasonality Move:
42.29%
Sell
49
RMD
ResMed
Last Price:
217.91
Seasonality Move:
6.4%
Buy
66
Novavax (NVAX)
is a Buy
Is Novavax a Buy, Sell or Hold?
- The current Novavax [NVAX] share price is $8.88. The Score for NVAX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- NVAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $213.82. The Score for RMD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 86.66 | Buy |
| Chaikin Money Flow: | -130595777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.55 - 5.43) | Buy |
| Bollinger Bands (100): | (3.97 - 5.29) | Buy |
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.78 | Buy |
| Relative Strength Index (14 RSI): | 62.72 | Buy |
| Chaikin Money Flow: | -394910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.16 - 214.58) | Buy |
| Bollinger Bands (100): | (173.25 - 199.25) | Buy |
NVAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.19 | Buy |
| 20-day SMA: | 4.52 | Buy |
| 50-day SMA: | 4.74 | Buy |
| 200-day SMA: | 5.83 | Buy |
| 8-day EMA: | 5.5 | Buy |
| 20-day EMA: | 4.87 | Buy |
| 50-day EMA: | 4.7 | Buy |
| 200-day EMA: | 6.85 | Buy |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 215.85 | Sell |
| 20-day SMA: | 200.4 | Buy |
| 50-day SMA: | 193.85 | Buy |
| 200-day SMA: | 172.14 | Buy |
| 8-day EMA: | 213.38 | Buy |
| 20-day EMA: | 205.47 | Buy |
| 50-day EMA: | 195.8 | Buy |
| 200-day EMA: | 185.62 | Buy |
Novavax Earnings Growth & NVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.70 per share, and an increase next year of $0.34 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.
Novavax Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ResMed Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||